Previous Statements by DYAX
» Dyax Corporation CEO Discusses 3Q 2010 Results - Earnings Call Transcript
» Dyax Corp. Q2 2010 Earnings Call Transcript
» Dyax Corporation Q1 2010 Earnings Call Transcript
» Dyax Q4 2009 Earnings Call Transcript
Ireland’s Shire has clinched Baxalta with a stock and cash deal worth $32 billion on Monday.
One of these biopharma executives, or the grouped nominees, will win the Swanson Trophy, named in honor of Robert Swanson, Genentech's founding CEO. Here are the best biopharma CEOs.
Trade-Ideas LLC identified Dyax (DYAX) as a pre-market mover with heavy volume candidate